BackPanacea Life Sciences Holdings Overview
Panacea Life Sciences Holdings, Inc.

Panacea Life Sciences Holdings Return on Equity

Latest ROE for Panacea Life Sciences Holdings: -515.73% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-515.73%

Return on Equity

-515.73%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Panacea Life Sciences Holdings (PLSH) FAQ

Panacea Life Sciences Holdings (PLSH) currently reports a ROE of -515.73%. That is below the sector sector average of 11.3%. Use the charts on this page to explore Panacea Life Sciences Holdings's ROE history and peer comparisons.

Panacea Life Sciences Holdings's ROE of -515.73% is lower than the its sector sector average of 11.3%. That is roughly 4665.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Panacea Life Sciences Holdings's current -515.73% should be judged against industry norms (sector average: 11.3%) and against PLSH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -515.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.3%. From there, open related valuation or income-statement pages for Panacea Life Sciences Holdings, and consider following PLSH for alerts when major investors trade the stock.